S'abonner

How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site identification is initially uncertain: A nationwide, multicenter, prospective study - 18/12/24

Doi : 10.1016/j.jaad.2024.08.073 
Areeba Ahmed, MD a, Amanda Maisel-Campbell, MD a, b, Victoria J. Shi, BS a, Eric Koza, BS a, Melissa Ma, BS a, Misha Haq, BS a, Umer Nadir, BS a, Michael D. Yi, BS a, Loma Dave, BS a, Farhana Ikmal Hisham, MA a, Katherine A. Lin, BS a, Sarah A. Ibrahim, MD a, Bianca Y. Kang, MD a, McKenzie A. Dirr, BA, BS a, Juliet L. Aylward, MD c, Omar Bari, MD d, e, Hamza Bhatti, DO f, g, Diana Bolotin, MD, PhD h, Basil S. Cherpelis, MD i, Joel L. Cohen, MD j, k, Sean Condon, MD l, m, Sheila Farhang, MD i, n, Bahar Firoz, MD, MPH f, Algin B. Garrett, MD o, Roy G. Geronemus, MD p, q, Nicholas J. Golda, MD r, Dyann Helming, BS r, Tatyana R. Humphreys, MD s, t, Eva A. Hurst, MD u, v, Oren H. Jacobson, BS w, x, S. Brian Jiang, MD d, Pritesh S. Karia, PhD, MPH y, Arash Kimyai-Asadi, MD z, David J. Kouba, MD aa, ab, M. Laurin Council, MD u, Marilyn Le, BA s, Deborah F. MacFarlane, MD ac, Ian A. Maher, MD ad, ae, Stanley J. Miller, MD af, Eduardo K. Moioli, MD, PhD h, Meghan Morrow, MD a, Julia Neckman, MD q, ag, Timothy Pearson, MD l, ah, Samuel R. Peterson, MD ai, Christine Poblete-Lopez, MD l, Chad L. Prather, MD aj, Jennifer S. Ranario, MD ac, Ashley G. Rubin, MD d, ak, Chrysalyne D. Schmults, MD y, Andrew M. Swanson, MD c, Christopher Urban, MD u, al, Y. Gloria Xu, MD, PhD c, Ross Pearlman, MD a, Simon Yoo, MD a, Vishnu Harikumar, MD a, Alexandra Weil, BS a, Matthew Schaeffer, MD a, Sanjana Iyengar, MD a, Emily Poon, PhD a, Brian A. Cahn, MD am, Murad Alam, MD, MSCI, MBA a,
a Department of Dermatology, Feinberg School of Medicine, Chicago, Illinois 
b Department of Dermatology, Columbia University Medical Center, New York, New York 
c Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 
d Mohs and Dermatologic Surgery Center, University of California, San Diego, California 
e Division of Dermatology, University of California, Los Angeles, California 
f Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey 
g The Skin Institute of South Florida, Coral Springs, Florida 
h Section of Dermatology, University of Chicago, Chicago, Illinois 
i Department of Dermatology and Cutaneous Surgery, University of South Florida College of Medicine, Tampa, Florida 
j AboutSkin Dermatology, Denver, Colorado 
k Department of Dermatology, University of California Irvine, Irvine, California 
l Department of Dermatology, Cleveland Clinic, Cleveland, Ohio 
m The Center for Dermatology Care, Thousand Oaks, California 
n Avant Dermatology and Aesthetics, Tucson, Arizona 
o Hunter Holmes McGuire VA Medical Center, Richmond, Virginia 
p Ronald O. Perelman Department of Dermatology, New York University Langone Medical Center, New York, New York 
q Laser and Skin Surgery Center of New York, New York, New York 
r Department of Dermatology, University of Missouri School of Medicine, Columbia, Missouri 
s Main Line Center for Skin Surgery, Bala Cynwyd, Pennsylvania 
t Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 
u Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri 
v Distinctive Dermatology, Fairview Heights, Illinois 
w Revere Health Central Utah Mohs, Provo, Utah 
x St George's University School of Medicine, Grenada, West Indies 
y Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 
z DermSurgery Associates, Houston, Texas 
aa Wayne State University School of Medicine, Detroit, Michigan 
ab Toledo Clinic Facial Plastics and Dermatology, Toledo, Ohio 
ac Department of Dermatology, Baylor College of Medicine, Houston, Texas 
ad Department of Dermatology, St Louis University, St Louis, Missouri 
ae Department of Dermatology, University of Minnesota, Minneapolis, Minnesota 
af Towson Dermatology, Towson, Maryland 
ag Metroderm, Atlanta, Georgia 
ah Anne Arundel Dermatology, Berlin, Maryland 
ai California Skin Institute, Newport Beach, California 
aj Dermasurgery Center, Baton Rouge, Louisiana 
ak Bernardo Dermatology Medical Group, Poway, California 
al Carolina Mountain Dermatology, Arden, North Carolina 
am Department of Dermatology, University of Illinois-Chicago, Chicago, Illinois 

Correspondence to: Murad Alam, MD, MSCI, MBA, Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N Saint Clair St, Suite 1600, Chicago, IL 60611.Department of DermatologyFeinberg School of MedicineNorthwestern University676 N Saint Clair StSuite 1600ChicagoIL60611

Abstract

Background

Few studies show how dermatologic surgeons manage problems with site identification.

Objective

To estimate frequency and characterize management of skin cancer treated by surgery when the anatomic location of the tumor is in question.

Methods

Nationwide, prospective, multisite cohort study.

Results

Among 17,076 cases at 22 centers, 98 (0.60%) were lesions in question for which site identification was initially uncertain, with these more often in patients who were male, older, and biopsied more than 30 days ago. Surgeons employed on average 5.0 (95% CI: 4.61-5.39) additional techniques to confirm the site location, with common approaches including: re-checking available documentation (90 lesions, 92%); performing an expanded physical examination (89 lesions, 91%); and asking the patient to point using a mirror (61 lesions, 62%). In 15%, photographs were requested from the biopsying provider, and also in 15%, frozen section biopsies were obtained. In 10%, the referring physician was contacted. Eventually, surgeons succeeded in definitively identifying 82% (80 of 98) of initially uncertain sites, with the remaining 18% (18 of 98) postponed. Most postponed surgeries were at non-facial sites.

Limitations

Sites were academic centers.

Conclusions

When the anatomic location of the tumor is uncertain, dermatologic surgeons use multiple methods to identify the site, and sometimes cases are postponed.

Le texte complet de cet article est disponible en PDF.

Key words : cutaneous surgery, dermbase, lesion in question, Mohs micrographic surgery, skin cancer, uncertain lesion location

Abbreviations used : IQR, LIQ


Plan


 Funding sources: None.
 Patient consent: Not applicable for recognizable or identifiable patient information in our publication. Consent for participation was obtained by the authors prior to enrollment in the study.
 IRB approval status: Study procedures were performed under the authorization of 2 expedited Northwestern University Institutional Review Board (IRB) protocols, which collectively authorized data collection and managed transmittal of de-identified data across institutions to enable analysis. All data collected were de-identified, and informed consent was waived per IRB direction.


© 2024  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 92 - N° 1

P. 85-91 - janvier 2025 Retour au numéro
Article précédent Article précédent
  • JAAD Game Changers: Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study
  • Adam Friedman
| Article suivant Article suivant
  • Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
  • Kexiang Yan, Fuqiu Li, Xiaodong Bi, Ling Han, Zhenghua Zhang, Rixin Chen, Yuye Li, Litao Zhang, Xiaohua Wang, Linfeng Li, Jianyun Lu, Ai'e Xu, Sen Yang, Yan Lu, Jianfang Sun, Zhiming Li, Xiaohong Zhu, Meiying Jiang, Siping Zhang, Wenqing Wang, Yanling Li, Zudong Meng, Hongyi Li, Kuanhou Mou, Xiuping Han, Shanshan Li, Aijun Chen, Xin Li, Donghua Liu, Chunlei Zhang, Chao Ji, Yu Wang, Hao Cheng, Xiaojing Cui, Xiaoyan Yao, Xiaoyan Bai, Guangchao Dong, Jinhua Xu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.